ZVRA — Zevra Therapeutics, Inc.
8 mentions in the last 24 hours · 0.04% of all mentions
Why people talked about ZVRA (2026-11-04)
- The revenue growth was primarily driven by rising sales of MIPLYFFA.
- The company released its quarterly earnings results and held an earnings call for the third quarter ended September 30, 2026.
| Bluesky | 3 | community |
| GDELT | 3 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |